WELBIO is an inter-university life sciences research institute based in Wallonia, Belgium. WELBIO is funded by the Walloon Region. Our mission is to support strategic fundamental research through carefully selected projects from universities in the Wallonia-Brussels Federation, with a view to transforming their discoveries into industrial applications in all fields of biotechnology.
Dr Alban de Kerchove d'Exaerde WELBIO Investigator at the Université libre de Bruxelles is the 2018 winner of the triennial prize awarded by the Pierre and Simone Clerdent Foundation.
A research team led by Decio Eizirik, Director of the ULB Center for Diabetes Research and WELBIO investigator, is working to understand the mechanisms that lead the immune system to recognize the patient’s own beta cells as foreign and attack them. A new study, published in Cell Metabolism, will contribute for a better prediction of the disease and open novel perspectives for the development of approaches to induce tolerance to the beta cells.
Led by Benoit Vanhollebeke, WELBIO investigator at the Université libre de Bruxelles (ULB), the Laboratory of Neurovascular Signaling (ULB’s Faculty of Sciences and ULB Neuroscience Institute) provides a molecular mechanism conferring ligand specificity to Wnt signaling, an ancestral communication pathway present in all vertebrates. Their research is published in Science.